| UNAIDS/WHO estimates that 42 million people are
living with HIV/AIDS worldwide and 50% of all adults with HIV
infection are women predominantly infected via heterosexual
transmission. Women with HIV infection, like other women, may
wish to plan pregnancy, limit their family, or avoid pregnancy.
Health professionals should enable these reproductive choices
by counselling and appropriate contraception provision at the
time of HIV diagnosis and during follow up. The aim of this
article is to present a global overview of contraception choice
for women living with HIV infection including
effects on sexual transmission risk.
Abbreviations:
-
COC - combined contraceptive
pill;
-
DMPA - depot medroxyprogesterone
acetate;
-
HAART - highly active
antiretroviral therapy;
-
IUDs - intrauterine
devices;
-
LNG-IUS - levonorgestrel
intrauterine system;
-
NET-EN - norethisterone
enanthate;
-
NNRTIs - non-nucleotide
reverse transcriptase inhibitors;
-
PID - pelvic inflammatory
disease;
-
PIs - protease inhibitors;
-
POP - progestogen only
pill
© 2004 BMJ Publishing Group Ltd |